Jonathan Cebon相关文献与解析，生知库 | 链接生命科学的每一步

Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Ben Markman, Damien Kee, Matteo S Carlino, Craig Underhill, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley0

免疫

肠癌

Checkpoint

发表日期：2024

文献求助收藏

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

罕见妇科恶性肿瘤患者使用纳武单抗和伊匹单抗进行联合免疫治疗：CA209-538 临床试验结果

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2021-003156

Oliver Klein, Damien Kee, Bo Gao, Ben Markman, Jessica da Gama Duarte, Luke Quigley, Louise Jackett, Richelle Linklater, Andrew Strickland, Clare Scott, Linda Mileshkin, Jodie Palmer, Matteo Carlino, Andreas Behren, Jonathan Cebon

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma

一种针对 BCL-XL 和 BCL-2 的新型 BH3 类似物 AZD0466 对恶性胸膜间皮瘤的临床前模型有效

期刊:Cell Death Discovery

影响因子:6.1

doi:10.1038/s41420-021-00505-0

Surein Arulananda, Megan O'Brien, Marco Evangelista, Laura J Jenkins, Ashleigh R Poh, Marzena Walkiewicz, Trishe Leong, John M Mariadason, Jonathan Cebon, Srividya B Balachander, Justin R Cidado, Erinna F Lee #, Thomas John #, Walter D Fairlie #

Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma

追踪细胞外囊泡表型变化可实现黑色素瘤治疗的监测。

期刊:Science Advances

影响因子:11.7

doi:10.1126/sciadv.aax3223

Jing Wang ，Alain Wuethrich ，Abu Ali Ibn Sina ，Rebecca E Lane ，Lynlee L Lin ，Yuling Wang ，Jonathan Cebon ，Andreas Behren ，Matt Trau

BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

BCL-XL 是治疗恶性胸膜间皮瘤的可行靶点

期刊:Cell Death Discovery

影响因子:6.1

doi:10.1038/s41420-020-00348-1

Surein Arulananda, Megan O'Brien, Marco Evangelista, Tiffany J Harris, Nikita S Steinohrt, Laura J Jenkins, Marzena Walkiewicz, Robert J J O'Donoghue, Ashleigh R Poh, Bibhusal Thapa, David S Williams, Trishe Leong, John M Mariadason, Xia Li, Jonathan Cebon, Erinna F Lee, Thomas John, W D Fairlie7

发表日期：2020

文献求助收藏

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival

BCL-XL 和 MCL-1 是黑色素瘤细胞存活的关键 BCL-2 家族蛋白

期刊:Cell Death & Disease

影响因子:8.1

doi:10.1038/s41419-019-1568-3

Erinna F Lee, Tiffany J Harris, Sharon Tran, Marco Evangelista, Surein Arulananda, Thomas John, Celeste Ramnac, Chloe Hobbs, Haoran Zhu, Gency Gunasingh, David Segal, Andreas Behren, Jonathan Cebon, Alexander Dobrovic, John M Mariadason, Andreas Strasser, Leona Rohrbeck, Nikolas K Haass, Marco J Her

Characterising the phenotypic evolution of circulating tumour cells during treatment

表征治疗期间循环肿瘤细胞的表型演变

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-018-03725-8

Simon Chang-Hao Tsao, Jing Wang, Yuling Wang, Andreas Behren, Jonathan Cebon, Matt Trau

Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide

HLA-I 限制性延伸肿瘤相关肽的不同 T 细胞受体识别模式

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-018-03321-w

Kok Fei Chan, Benjamin S Gully, Stephanie Gras, Dennis X Beringer, Lars Kjer-Nielsen, Jonathan Cebon, James McCluskey, Weisan Chen, Jamie Rossjohn

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma

自身抗体可能预测免疫相关毒性：晚期转移性黑色素瘤患者病灶内注射卡介苗，随后接受伊匹单抗治疗的 I 期研究结果

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2018.00411

Jessica Da Gama Duarte, Sagun Parakh, Miles C Andrews, Katherine Woods, Anupama Pasam, Candani Tutuka, Simone Ostrouska, Jonathan M Blackburn, Andreas Behren, Jonathan Cebon

Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules

限制于各种 MHC 分子的 NY-ESO-1 特异性 T 细胞受体的分离和表征

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:

doi:10.1073/pnas.1810653115

Michael T Bethune, Xiao-Hua Li, Jiaji Yu, Jami McLaughlin, Donghui Cheng, Colleen Mathis, Blanca Homet Moreno, Katherine Woods, Ashley J Knights, Angel Garcia-Diaz, Stephanie Wong, Siwen Hu-Lieskovan, Cristina Puig-Saus, Jonathan Cebon, Antoni Ribas, Lili Yang, Owen N Witte, David Baltimore

A gut microbial signature for combination immune checkpoint blockade across cancer types

针对不同癌症类型联合免疫检查点阻断的肠道微生物特征

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

罕见妇科恶性肿瘤患者使用纳武单抗和伊匹单抗进行联合免疫治疗：CA209-538 临床试验结果

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma

一种针对 BCL-XL 和 BCL-2 的新型 BH3 类似物 AZD0466 对恶性胸膜间皮瘤的临床前模型有效

Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma

追踪细胞外囊泡表型变化可实现黑色素瘤治疗的监测。

BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

BCL-XL 是治疗恶性胸膜间皮瘤的可行靶点

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival

BCL-XL 和 MCL-1 是黑色素瘤细胞存活的关键 BCL-2 家族蛋白

Characterising the phenotypic evolution of circulating tumour cells during treatment

表征治疗期间循环肿瘤细胞的表型演变

Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide

HLA-I 限制性延伸肿瘤相关肽的不同 T 细胞受体识别模式

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma

自身抗体可能预测免疫相关毒性：晚期转移性黑色素瘤患者病灶内注射卡介苗，随后接受伊匹单抗治疗的 I 期研究结果

Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules

限制于各种 MHC 分子的 NY-ESO-1 特异性 T 细胞受体的分离和表征